We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OTRK
2826
DELISTED
Ontrak
OTRK
| $270K | ﹤0.01% |
93
-5
| -5% | -$14.4K |
|
|
VOXX
2827
DELISTED
VOXX International Corporation Class A
VOXX
| $270K | ﹤0.01% |
19,260
-6,972
| -27% | -$113K |
|
2828
Lifetime Brands
LCUT
$199M
| $269K | ﹤0.01% |
17,968
-1,650
| -8% | -$25.3K |
|
2829
Solid Biosciences
SLDB
$857M
| $267K | ﹤0.01% |
4,862
+2,525
| +108% | +$167K |
|
2830
Arbutus Biopharma
ABUS
$897M
| $266K | ﹤0.01% |
+87,918
| New | +$272K |
|
|
FRBK
2831
DELISTED
Republic First Bancorp Inc
FRBK
| $266K | ﹤0.01% |
66,602
-7,877
| -11% | -$31.6K |
|
2832
FS KKR Capital
FSK
$3.28B
| $264K | ﹤0.01% |
+12,272
| New | +$263K |
|
2833
Eterna Therapeutics
ERNA
$5.09M
| $263K | ﹤0.01% |
+2
| New | +$288K |
|
2834
Dianthus Therapeutics
DNTH
$6.15B
| $262K | ﹤0.01% |
1,674
+128
| +8% | +$23.5K |
|
|
NBEV
2835
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $262K | ﹤0.01% |
117,477
+15,965
| +16% | +$37.2K |
|
|
BHR
2836
Braemar Hotels & Resorts
BHR
$146M
| $261K | ﹤0.01% |
+42,015
| New | +$259K |
|
|
PARAA
2837
DELISTED
Paramount Global Class A
PARAA
| $261K | ﹤0.01% |
5,393
-2,125
| -28% | -$96.8K |
|
2838
Transcat
TRNS
$885M
| $261K | ﹤0.01% |
4,624
-428
| -8% | -$22.3K |
|
2839
Coastal Financial
CCB
$671M
| $260K | ﹤0.01% |
9,106
-3,734
| -29% | -$109K |
|
2840
Oil-Dri
ODC
$1.4B
| $260K | ﹤0.01% |
15,234
-2,232
| -13% | -$39.6K |
|
2841
Flexsteel Industries
FLXS
$313M
| $259K | ﹤0.01% |
+6,409
| New | +$279K |
|
2842
Spero Therapeutics
SPRO
$73.5M
| $259K | ﹤0.01% |
18,565
+126
| +0.7% | +$1.76K |
|
2843
Teekay
TK
$981M
| $259K | ﹤0.01% |
+69,669
| New | +$246K |
|
|
TRVN
2844
DELISTED
Trevena, Inc.
TRVN
| $259K | ﹤0.01% |
+245
| New | +$275K |
|
|
ATHX
2845
DELISTED
Athersys, Inc. Common Stock
ATHX
| $259K | ﹤0.01% |
7,199
+5
| +0.1% | +$206 |
|
|
ICAD
2846
DELISTED
iCAD Inc
ICAD
| $258K | ﹤0.01% |
14,878
-497
| -3% | -$8.72K |
|
|
TBHC
2847
DELISTED
The Brand House Collective
TBHC
| $258K | ﹤0.01% |
+11,293
| New | +$303K |
|
|
LOTZ
2848
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $258K | ﹤0.01% |
+47,268
| New | +$298K |
|
2849
Nature's Sunshine
NATR
$358M
| $257K | ﹤0.01% |
14,785
+341
| +2% | +$6.74K |
|
2850
Aligos Therapeutics
ALGS
$34.1M
| $256K | ﹤0.01% |
+502
| New | +$320K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.